Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer

Gianluca Civenni1, Giuseppina M Carbone1, Carlo V Catapano1

  • 1Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.

Insights

Therapy-resistant prostate cancer stem cells (CSCs) hinder treatment. Bromodomain Containing 4 (BRD4) drives CSC expansion by promoting mitochondrial fission, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Prostate cancer treatment efficacy is limited by therapy-resistant cancer stem cells (CSCs).
  • Cancer stem cells are crucial for tumor recurrence and metastasis.

Purpose of the Study:

  • To investigate the role of Bromodomain Containing 4 (BRD4) in the expansion and maintenance of prostate cancer stem cells.
  • To explore the molecular mechanisms by which BRD4 influences cancer stem cell properties.

Main Methods:

  • Utilized genetic knockdown techniques to reduce BRD4 expression in prostate cancer cells.
  • Employed chemical inhibitors targeting BRD4 activity.
  • Assessed the impact of BRD4 modulation on mitochondrial fission and CSC populations.

Main Results:

  • Bromodomain Containing 4 (BRD4) was found to be critical for sustaining cancer stem cell expansion.
  • BRD4 promotes mitochondrial fission, a process essential for cancer stem cell survival and proliferation.
  • Inhibition of BRD4 led to decreased CSC populations.

Conclusions:

  • Bromodomain Containing 4 (BRD4) plays a pivotal role in the biology of therapy-resistant prostate cancer stem cells.
  • Targeting BRD4 and its downstream effects on mitochondrial dynamics presents a novel therapeutic strategy for prostate cancer.
  • These findings open new avenues for overcoming treatment resistance in prostate cancer.

Related Concept Videos

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

The isolation of cancer stem cells (CSCs) directly from human tissues is requisite for their biological characterization. This manuscript describes a methodology for the isolation of prostate CSCs from human tissues, while also providing tips on troubleshooting difficult...
14.6K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

This orthotopic model of human prostate cancer allows for quantification of tumor size, circulating tumor cells, and formation of distinct metastasis to the lung. As cells must escape the primary organ, enter the blood stream, and implant into a secondary site, this model effectively recapitulates the scenario in...
35.8K
Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model05:07

Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model

In this video, we demonstrate the procedure for administering intra-prostatic injection of prostate cancer cells into a mouse model. Orthotopic murine models can be used to study the disease origin and response to treatment therapies in a non-invasive and clinically relevant...
5.6K
Nuclear Fission02:50

Nuclear Fission

Many heavier elements with smaller binding energies per nucleon can decompose into more stable elements that have intermediate mass numbers and larger binding energies per nucleon—that is, mass numbers and binding energies per nucleon that are closer to the “peak” of the binding energy graph near 56. Sometimes neutrons are also produced. This decomposition of a large nucleus into smaller pieces is called fission. The breaking is rather random with the formation of a large...
12.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Prostate cancer is the second most common cause of cancer-related deaths in the United States. An orthotopic cancer model provides a useful approach to understand the biology of prostate cancer and to evaluate the efficacy of therapeutic regimens. This protocol describes detailed steps necessary to establish an orthotopic prostate cancer mouse...
15.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Here we describe a simplified protocol for microRNA (miRNA) expression analyses in archived Formalin-Fixed, Paraffin-Embedded (FFPE) or fresh frozen prostate cancer (PCa) clinical tissues employing quantitative real-time PCR (RT-PCR) and in situ hybridization...
11.2K